Amrutanjan Health Care Complete Financial Statements

AMRUTANJAN • Review detailed financials to uncover trends, confirm thesis & journal trades
2 Years of Data
2016 - 2015

Complete Financial Data Export

Export complete financial statements for Amrutanjan Health Care (AMRUTANJAN). Downloads include all available records across all periods. For market performance, see the AMRUTANJAN stock price today .

Profitability Ratios

Net Profit Margin 10.94% 2016 data
EBITDA Margin 19.27% 2016 data
Operating Margin 16.00% 2016 data
Return on Assets 15.00% 2016 data
Return on Equity 19.27% 2016 data

Balance Sheet Ratios

Current Ratio 25.25 2016 data
Debt to Equity 1.28 2016 data
Equity Ratio 77.86% 2016 data
Asset Turnover 1.37 2016 data

Year-over-Year Growth Analysis

Comparing March 2016 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+12.9%
Year-over-Year
Equity Growth
+14.7%
Year-over-Year
Liabilities Growth
+12.9%
Year-over-Year
Operating Cash Flow Growth
+16.7%
Year-over-Year
Investing Cash Flow Growth
+180.0%
Year-over-Year
Financing Cash Flow Growth
-8.3%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars None March 2016 March 2015
Revenue 0 192 171
Expenses 0 156 143
EBITDA 0 37 28
Operating Profit Margin % 0.00% 16.00% 14.00%
Depreciation 0 3 3
Interest 0 0 1
Profit Before Tax 0 32 24
Tax 0 12 9
Net Profit 0 21 15
Earnings Per Share (₹) 0.00 14.08 10.31

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2016 2015
ASSETS
Total Assets 140 124
Current Assets 101 83
Fixed Assets 29 24
Capital Work in Progress 1 4
Investments 0 0
Other Assets 111 96
LIABILITIES
Total Liabilities 140 124
Current Liabilities 4 3
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 109 95
Share Capital 3 3
Reserves & Surplus 106 92

Cash Flow Statement

Periods ₹ Crores
Particulars March 2016 March 2015
Operating Activities 21 18
Investing Activities 4 -5
Financing Activities -13 -12
Net Cash Flow 12 2